Given the vital role of the interaction between lncRNAs and the PI3K-AKT pathway in gastrointestinal tumors, further research is essential to fill this gap and develop viable treatment strategies that can significantly improve patient outcomes. This evidence concerns the gene PIK3CA and digestive system neoplasm.